跳至主要内容
临床试验/NCT06304909
NCT06304909已完成1 期

Effect of Intravenous Dexmedetomidine Versus Dexamethasone for Management of Repound Pain After Supraclavicular Brachial Plexus Block

Assiut University1 个研究点 分布在 1 个国家目标入组 111 人开始时间: 2024年5月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
111
试验地点
1
主要终点
The incidence of rebound pain.

研究概览

简要总结

Effect of intravenous dexmedetomidine versus dexamethasone for management of repound pain after supraclavicular brachial plexus block.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
20 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Patients between 20_60 years old
  • Patients with ASA clinical status I/II
  • Patients scheduled for peripheral nerve block for upper extremity surgery

排除标准

  • 1) they refused to participate 2) had preexisting neuropathy of the surgical limb 3) hypersensitivity to amide anesthetic 4) significant pulmonary disease 5) coagulopathy 6) sepsis 7) infection at the block site 8) hypersensitivity to dexmedetomidine & dexamethasone

研究组 & 干预措施

Dexmedetomidine group will receive 0.5 mcg/kg

Experimental

干预措施: Dexmedetomidine injection (Drug)

Dexamethasone group will receive 8mg/kg

Experimental

干预措施: Dexmedetomidine injection (Drug)

Control group will receive equivalent volume of saline 0.9%.

Experimental

干预措施: Dexmedetomidine injection (Drug)

结局指标

主要结局

The incidence of rebound pain.

时间窗: 1year

Rebound pain is defined as an increase from well-controlled to severe pain typically within 12\_24 h of resolution of the nerve block.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Marwa Sayed Mohamed Ahmed

Resident

Assiut University

研究点 (1)

Loading locations...

相似试验